| N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide |
N-(1-羟基-2-(羟甲基)-4-(4-辛基苯基)丁-2-基)乙酰胺 |
249289-10-9 |
| OMALIZUMAB |
奥马珠单抗 |
242138-07-4 |
| 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER |
3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯 |
212322-56-0 |
| 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester |
3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯 |
211915-84-3 |
| Dabigatran etexilate |
达比加群酯 |
211915-06-9 |
| INDOLE-7-BORONIC ACID |
吲哚-7-硼酸 |
210889-31-9 |
| 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one |
9-溴-3-(2-溴乙酰基)-10,11-二氢-5H-二苯并(C,G) CHROMEN-8(9H)-酮 |
1438383-89-1 |
| (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid |
(5S)-N-(甲氧羰基)-L-缬氨酰-5-甲基-L-脯氨酸 |
1335316-40-9 |
| 1-(2-MethylpyriMidin-5-yl)ethanaMine |
1-(2-甲基嘧啶-5-基)乙胺 |
1071435-99-8 |
| Sofosbuvir |
索非布韦 |
1190307-88-0 |
| (1R trans)-2-(3,4-difluorophenyl)cyclopropane amine |
(1R,2S)-REL-2-(3,4-二氟苯基)环丙胺盐酸盐 |
1156491-10-9 |
| (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid |
(2R,4S)-5-(联苯-4-基)-4-[(叔丁氧基羰基)氨基]-2-甲基戊酸 |
1012341-50-2 |
| (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride |
(3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺盐酸盐 |
1062580-52-2 |
| 2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene |
2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩 |
1030825-20-7 |
| (R)-1-Boc-3-Aminopiperidine |
(R)-1-叔丁氧羰基-3-氨基哌啶 |
188111-79-7 |
| Etanercept |
依那西普 |
185243-69-0 |
| 6-broMo-2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one |
6-溴-2-氯-8-环戊基-5-甲基-吡啶并[2,3-D]嘧啶-7(8H)-酮 |
1016636-76-2 |
| 11-Chloro-2,3-dihydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one |
11-氯-2,3-二氢-2-甲基-1H-二苯并[2,3:6,7]氧杂卓并[4,5-C]吡咯-1-酮 |
1012884-46-6 |
| Trastuzumab |
曲妥珠单抗 |
180288-69-1 |
| Rituximab |
利妥昔单抗 |
174722-31-7 |
